[1]Siegel R L, Miller K D, Jemal A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1): 7-30.
[2]Zhu L P, Li J N, Guo Z A, et al. Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy[J]. J Nanobiotechnology, 2022, 20(1): 521.
[3]Kong C, Chen X. Combined photodynamic and photothermal therapy and immunotherapy for cancer treatment: a review[J]. Int J Nanomedicine, 2022, 17(1): 6427-6446.
[4]Liu S W, Wei W F, Wang J L, et al. Theranostic applications of selenium nanomedicines against lung cancer[J]. J Nanobiotechnology, 2023, 21(1): 96.
[5]Vaughan H J, Green J J, Tzeng S Y. Cancer-targeting nanoparticles for combinatorial nucleic acid delivery[J]. Adv Mater, 2020, 32(13): e1901081.
[6]Deryugina A V, Danilova D A, Polozova A V. Application of molecular hydrogen in early heart failure development: modulation of microcirculation, metabolism, oxidative stress, and myocardial status[J]. Antioxidants, 2025, 14(12): 1418.
[7]Miranda M R, Basilicata M G, Vestuto V, et al. Anticancer therapies based on oxidative damage: Lycium barbarum inhibits the proliferation of MCF-7 cells by activating pyroptosis through endoplasmic reticulum stress[J]. Antioxidants, 2024, 13(6): 708.
[8]Fan W P, Yung B, Huang P, et al. Nanotechnology for multimodal synergistic cancer therapy[J]. Chem Rev, 2017, 117(22): 13566-13638.
[9]Gong Z C, Kang G B, Cao Y, et al. Flexible regulation of optical properties based on structure size-driven intermolecular interactions for phototherapy[J]. Adv Sci, 2025, 12(27): e2501468.
[10]Caine J R, Larsen S, Ghosh A, et al. Near-infrared photothermal conversion by isocorrole and phlorin derivatives[J]. Inorg Chem, 2025, 64(3): 1246-1251.
[11]Chen J F, Zhang X W, Sun J P, et al. Photothermal nano-agents: an innovative trident weapon for accurate and effective treatment of Alzheimer’s disease[J]. J Nanobiotechnology, 2025, 23(1): 650.
[12]Tao Y, Chan H F, Shi B Y, et al. Light: a magical tool for controlled drug delivery[J]. Adv Funct Mater, 2020, 30(49): 2005029.
[13]Fan S H, Lin W S, Huang Y F, et al. Advances and potentials of polydopamine nanosystem in photothermal-based antibacterial infection therapies[J]. Front Pharmacol, 2022, 13: 829712.
[14]Li B, Fu G G, Liu C, et al. Ti2C3 MXene-based nanocomposite as an intelligent nanoplatform for efficient mild hyperthermia treatment[J]. J Colloid Interface Sci, 2024, 665: 389-398.
[15]He X, Zhang S T, Tian Y H, et al. Research progress of nanomedicine-based mild photothermal therapy in tumor[J]. Int J Nanomedicine, 2023, 18: 1433-1468.
[16]Kesharwani P, Ma R Y, Sang L, et al. Gold nanoparticles and gold nanorods in the landscape of cancer therapy[J]. Mol Cancer, 2023, 22(1): 98.
[17]Gu J Y, He Y Y, He C X, et al. Advances in the structures, mechanisms and targeting of molecular chaperones[J]. Signal Transduct Target Ther, 2025, 10(1): 84.
[18]Yu K X, Zhou H, Xu Y M, et al. Engineering a triple-functional magnetic gel driving mutually-synergistic mild hyperthermia-starvation therapy for osteosarcoma treatment and augmented bone regeneration[J]. J Nanobiotechnology, 2023, 21(1): 201.
[19]Dang J J, Ye H, Li Y J, et al. Multivalency-assisted membrane-penetrating siRNA delivery sensitizes photothermal ablation via inhibition of tumor glycolysis metabolism[J]. Biomaterials, 2019, 223: 119463.
[20]Li Z, Sun L Y, Lan J S, et al. Illuminating the fight against breast cancer: preparation and visualized photothermal therapy of hyaluronic acid coated ZIF-8 loading with indocyanine green and cryptotanshinone for triple-negative breast cancer[J]. Mater Today Bio, 2024, 28: 101200.
[21]Liu H, Yang W Y, Jiang J W. Targeting tumor metabolism to augment CD8+ T cell anti-tumor immunity[J]. J Pharm Anal, 2025, 15(5): 101150.
[22]Wang C D, Li Z P, Xu P, et al. Combination of polythyleneimine regulating autophagy prodrug and Mdr1 siRNA for tumor multidrug resistance[J]. J Nanobiotechnology, 2022, 20(1): 476.
[23]Li M M, Chen F L, Yang Q, et al. Biomaterial-based CRISPR/Cas9 delivery systems for tumor treatment[J]. Biomater Res, 2024, 28: 0023.
[24]Hamada E, Kurosaki T, Hashizume J, et al. Anionic complex with efficient expression and good safety profile for mRNA delivery[J]. Pharmaceutics, 2021, 13(1): 126.
[25]Zhupanyn P, Ewe A, Büch T, et al. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo[J]. J Control Release, 2020, 319: 63-76.
[26]Van Den Tempel N, Horsman M R, Kanaar R. Improving efficacy of hyperthermia in oncology by exploiting biological mechanisms[J]. Int J Hyperthermia, 2016, 32(4): 446-454.
|